PRIMARY SCLEROSING CHOLANGITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Primary sclerosing cholangitis Market, By Drug Class (Ursodeoxycholic acid (UDCA), Corticosteroids, Azathioprine, Mercaptopurine, Budesonide, Obeticholic acid, Monoclonal antibody, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 03 Apr, 2026
Code: CMI1960
Page number: 134
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Class
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Primary Sclerosing Cholangitis Market, By Drug Class, 2021 – 2033, (USD Mn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Ursodeoxycholic acid (UDCA)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Corticosteroids
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Azathioprine
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Mercaptopurine
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Budesonide
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Obeticholic acid
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Monoclonal antibody
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Primary Sclerosing Cholangitis Market, By Route of Administration, 2021 – 2033, (USD Mn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Oral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Parenteral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Primary Sclerosing Cholangitis Market, By Distribution Channel, 2021 – 2033, (USD Mn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Retail Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Online Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Primary Sclerosing Cholangitis Market, By Region, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Region, 2021–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Acorda Therapeutics, Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Gilead Sciences, Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - NGM Biopharmaceuticals, Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Intercept Pharmaceuticals, Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Dr. Falk Pharma GmbH
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Allergan Plc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Shire Plc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Durect Corporation
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Conatus Pharmaceuticals, Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sirnaomics, Inc.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Shenzhen HighTide Biopharmaceutical Ltd.
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Cymabay Therapeutics
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pliant Therapeutics
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Immunic AG
    - Company Highlights
    - Method Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact

*Browse 32 market data tables and 28 figures on "Primary Sclerosing Cholangitis Market” -Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now